Cargando…
Anxiolytic activity of pyridoindole derivatives SMe1EC2 and SMe1M2: behavioral analysis using rat model
Anxiety and mood disorders have become very significant affections in the last decades. According to WHO at least one mental disease occurred per year in 27% of EU inhabitants (more than 82 mil. people). It is estimated that by 2020, depression will be the main cause of morbidity in the developed co...
Autores principales: | Sedláčková, Natália, Ponechalová, Veronika, Ujházy, Eduard, Dubovický, Michal, Mach, Mojmír |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Slovak Toxicology Society SETOX
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274730/ https://www.ncbi.nlm.nih.gov/pubmed/22319256 http://dx.doi.org/10.2478/v10102-011-0032-8 |
Ejemplares similares
-
Safety assessment of the pyridoindole derivative SMe1EC2: developmental neurotoxicity study in rats
por: Ujházy, Eduard, et al.
Publicado: (2011) -
Pyridoindole SMe1EC2 as cognition enhancer in ageing-related cognitive decline
por: Mrvová, Nataša, et al.
Publicado: (2017) -
The new pyridoindole antioxidant SMe1EC2 and its intervention in hypoxia/hypoglycemia-induced impairment of longterm potentiation in rat hippocampus
por: Gáspárová, Zdenka, et al.
Publicado: (2011) -
Antioxidant action of SMe1EC2, the low-basicity derivative of the pyridoindole stobadine, in cell free chemical models and at cellular level
por: Balcerczyk, Aneta, et al.
Publicado: (2014) -
Electrophysiology and Behavioral Assessment of the New Molecule SMe1EC2M3 as a Representative of the Future Class of Triple Reuptake Inhibitors
por: Koprdova, Romana, et al.
Publicado: (2019)